«Умное» пищеварение — наше «нет» ФРП

1. Бондаренко В.М., Мацулевич Т.В. Дисбактериоз кишечника как клинико – лабораторный синдром: современное состояние проблемы. Москва: ГЭОТАР-Медиа 2007.
2. Boulangé C.L., Neves A.L., Chilloux J., Nicholson J.K., Dumas M. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine 2016.
3. Zhang Y., Zhang H. Microbiota associated with type 2 diabetes and its related complications. Food Science and Human Wellness 2013.
4. Jose P.A., Raj D. Gut microbiota in hypertension. Curr Opin Nephrol Hypertens 2015.
5. Kostic A.D., Xavier R.J., Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014.
6. Lynch S.V. Gut Microbiota and Allergic Disease. Ann Am Thorac 2016.
7. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009.
8. Бондаренко В.М., Рябиченко Е.В. Кишечно-мозговая ось. Нейронные и иммуновоспалительные механизмы патологии мозга и кишечника // Журнал микробиологии, эпидемиологии и иммунобиологии. 2013.
9. Foster JA. Gut feelings: bacteria and the brain. Cerebrum. 2013.
10. Hesla H.M., Stenius F., Jäderlund L., Nelson R., Engstrand L., Alm J. et al. Impact of lifestyle on the gut microbiota of healthy infants and their mothers–the ALADDIN birth cohort. Microbiol Ecol 2014.
11. Reuter G. The Lactobacillus and Bifidobacterium Microflora of the Human Intestine: Composition and Succession. Curr Issues Intest Microbiol, 2001.
12. Axelsson LT, Chung TC, Dobrogosz WJ, Lindgren SE. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. MicrobEcol Health Dis, 1989.
13. Savino, Francesco et al. “Lactobacillus reuteri DSM 17938 in Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial.” Pediatrics 126 (2010).
14. Abrahamsson Т., Jakobsson T. et al. Intestinal microbiota in infants supplemented with the probiotic bacterium Lactobacillus reuteri. J Ped Gastroenterol Nutr 2005.
15. Wang Z, Wang L, Chen Z, Ma X, Yang X, Zhang J, et al. In vitro evaluation of swine-derived Lactobacillus reuteri: probiotic properties and effects on intestinal porcine epithelial cells challenged with enterotoxigenic Escherichia coli K88. J. Microbiol. Biotechnol. 2016.
16. Gabriela Bergonzelli Degonda (Bussigny), Magali Faure (Forel), Nicole Kusy (Montet). Lactobacillus Reuteri DSM 17938 for the Development of the Enteric Nervous System Patent Application (Application #20140363409); EP20110196138 20111230; Dec 11, 2014.
17. Perez-Burgos A, Wang L, McVey Neufeld KA, Mao Y-K, Ahmadzair M, Janssen LJ, et al. The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J. Physiol. 2015.
18. Indrio F, Di Mauro A. et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014.
19. Корниенко Е.А., Козырева Л.С. и др. Микробный метаболизм и кишечное воспаление у детей первого полугодия жизни в зависимости от вида вскармливания, Педиатрия, 2016.
20. Скрипченко Н.В., Федорова Л.А. и др. Питание и развитие мозга: вклад в будущее или упущенные возможности? Педиатрия им Г.Н.Сперанского. 2020.